Article
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
JAMA - 5 Sept 2017
Mandelker Diana, Zhang Liying, Kemel Yelena, Stadler Zsofia K, Joseph Vijai, Zehir Ahmet, Pradhan Nisha, Arnold Angela, Walsh Michael F, Li Yirong, Balakrishnan Anoop R, Syed Aijazuddin, Prasad Meera, Nafa Khedoudja, Carlo Maria I, Cadoo Karen A, Sheehan Meg, Fleischut Megan H, Salo-Mullen Erin, Trottier Magan, Lipkin Steven M, Lincoln Anne, Mukherjee Semanti, Ravichandran Vignesh, Cambria Roy, Galle Jesse, Abida Wassim, Arcila Marcia E, Benayed Ryma, Shah Ronak, Yu Kenneth, Bajorin Dean F, Coleman Jonathan A, Leach Steven D, Lowery Maeve A, Garcia-Aguilar Julio, Kantoff Philip W, Sawyers Charles L, Dickler Maura N, Saltz Leonard, Motzer Robert J, O'Reilly Eileen M, Scher Howard I, Baselga Jose, Klimstra David S, Solit David B, Hyman David M, Berger Michael F, Ladanyi Marc, Robson Mark E, Offit Kenneth
Abstract excerpt
Importance: Guidelines for cancer genetic testing based on family history may miss clinically actionable genetic changes with established implications for cancer screening or prevention. Objective: To determine the proportion and potential clinical implications of inherited variants detected using simultaneous sequencing of the tumor and normal tissue ("tumor-normal sequencing") compared with genetic test results...
Topics
- Aged
- Biomarkers, Tumor
- DNA Mutational Analysis
- DNA, Neoplasm
- Female
